Exact Mass: 520.1369

Exact Mass Matches: 520.1369

Found 14 metabolites which its exact mass value is equals to given mass value 520.1369, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Mometasone furoate

Mometasone furoate

C27H30Cl2O6 (520.1419)


C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C29629 - Combination Medication > C29639 - Topical Preparation > C29505 - Topical Corticosteroid C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D000893 - Anti-Inflammatory Agents D018926 - Anti-Allergic Agents D003879 - Dermatologic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS CONFIDENCE standard compound; INTERNAL_ID 2834

   

Mometasone furoate

[(8S,9R,10S,11S,13S,14S,16R,17R)-9-chloro-17-(2-chloroacetyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] furan-2-carboxylate

C27H30Cl2O6 (520.1419)


   

diacetylkielcorin|Kielcorindiacetat

diacetylkielcorin|Kielcorindiacetat

C28H24O10 (520.1369)


   

penicillanthranin A

penicillanthranin A

C28H24O10 (520.1369)


   

Mometasone

Mometasone

C27H30Cl2O6 (520.1419)


   

Eprosartan mesylate

Eprosartan mesylate

C24H28N2O7S2 (520.1338)


C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C66930 - Angiotensin II Receptor Antagonist D057911 - Angiotensin Receptor Antagonists > D057912 - Angiotensin II Type 2 Receptor Blockers D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents Eprosartan mesylate (SKF-108566J) is a selective, competitive, nonpeptid and orally active angiotensin II receptor antagonist, used as an antihypertensive. Eprosartan mesylate binds angiotensin II receptor with IC50s of 9.2 nM and 3.9 nM in rat and human adrenal cortical membranes, respectively[1].

   

2,24,4-tetrahydroxybenzophenone and 2,2-dihydroxy-4,4-dimethoxybenzophenone

2,24,4-tetrahydroxybenzophenone and 2,2-dihydroxy-4,4-dimethoxybenzophenone

C28H24O10 (520.1369)


   

ClindaMycin 2-Phosphate Sulfoxide

ClindaMycin 2-Phosphate Sulfoxide

C18H34ClN2O9PS (520.1411)


   

Apalcillin(1-)

Apalcillin(1-)

C25H22N5O6S- (520.1291)


   

[(8S,9S,10S,11R,13S,14S,16R,17S)-9-chloro-17-(2-chloroacetyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] furan-2-carboxylate

[(8S,9S,10S,11R,13S,14S,16R,17S)-9-chloro-17-(2-chloroacetyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] furan-2-carboxylate

C27H30Cl2O6 (520.1419)


   

[(2s,3s)-2-[4-(acetyloxy)-3-methoxyphenyl]-12-methoxy-10-oxo-2,3-dihydro-1,4,5-trioxatetraphen-3-yl]methyl acetate

[(2s,3s)-2-[4-(acetyloxy)-3-methoxyphenyl]-12-methoxy-10-oxo-2,3-dihydro-1,4,5-trioxatetraphen-3-yl]methyl acetate

C28H24O10 (520.1369)


   

{2-[4-(acetyloxy)-3-methoxyphenyl]-12-methoxy-10-oxo-2,3-dihydro-1,4,5-trioxatetraphen-3-yl}methyl acetate

{2-[4-(acetyloxy)-3-methoxyphenyl]-12-methoxy-10-oxo-2,3-dihydro-1,4,5-trioxatetraphen-3-yl}methyl acetate

C28H24O10 (520.1369)


   

6,8-dihydroxy-3,4,5-trimethyl-1-(1,3,8-trihydroxy-6-methyl-9,10-dioxoanthracen-2-yl)-3,4-dihydro-1h-2-benzopyran-7-carboxylic acid

6,8-dihydroxy-3,4,5-trimethyl-1-(1,3,8-trihydroxy-6-methyl-9,10-dioxoanthracen-2-yl)-3,4-dihydro-1h-2-benzopyran-7-carboxylic acid

C28H24O10 (520.1369)


   

(1s,3r,4s)-6,8-dihydroxy-3,4,5-trimethyl-1-(1,3,8-trihydroxy-6-methyl-9,10-dioxoanthracen-2-yl)-3,4-dihydro-1h-2-benzopyran-7-carboxylic acid

(1s,3r,4s)-6,8-dihydroxy-3,4,5-trimethyl-1-(1,3,8-trihydroxy-6-methyl-9,10-dioxoanthracen-2-yl)-3,4-dihydro-1h-2-benzopyran-7-carboxylic acid

C28H24O10 (520.1369)